New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

West Pharmaceutical Services, Inc.

WST

Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue
+8.69%
EPS
+57.3%
Free cash flow
+12.3%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

390.56 6.13 −1.55%

After hours trading: 390.30, down 0.07%, last trade 5:54pm Eastern.

Market cap
$27.6B
P/E
43.5×
Fwd P/E FY26e
44.6×
Dividend yield
0.24%
F-score
8/9
ROIC
18.0%
Net debt / EBITDA
−0.8×
Payout ratio
0.1×

West Pharmaceutical Services, Inc. (WST) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Proprietary Products 2,492 81.07%
West Vantage 582 18.93%
Gross margin 35.91%
Operating margin 19.03%
Pre-tax margin 19.55%

Revenue by segment $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
Proprietary Products 2,492 2,335 2,397 2,407 2,317 1,649 1,399 1,309 1,237 1,190 1,098 1,126 996 915 857 785 776
West Vantage 582 559 553 480 515 499 442 409 363 320 302 296 374 352 337 324 285
Corporate and Eliminations — — — — — — — — 0 (1) (1) (1) (2) (1) (2) (4) —
Intersegment Eliminations — — — — — — — — 0 (1) (1) (1) (2) (1) (2) (4) —
Other Unallocated Items — — — — — — — — — — — — — — — — (5)
Revenue 3,074 2,893 2,950 2,887 2,832 2,147 1,840 1,717 1,599 1,509 1,400 1,421 1,368 1,266 1,192 1,105 1,056

Operating income by segment $m, and margin

Revenue by region $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
United States 1,330 1,231 1,239 1,287 1,198 976 815 766 735 738 667 631 589 593 544 528 503
Other European countries 451 386 388 359 341 237 251 231 201 268 252 285 279 251 243 226 209
Germany 380 373 406 399 474 282 236 236 226 201 194 219 220 184 184 152 148
Other 353 339 349 364 357 254 213 202 194 186 179 168 168 135 128 110 90
Ireland 333 323 286 240 248 226 174 138 101 — — — — — — — —
France 227 242 283 238 213 173 151 145 143 116 108 118 113 103 94 89 105
Revenue 3,074 2,893 2,950 2,887 2,832 2,147 1,840 1,717 1,599 1,509 1,400 1,421 1,368 1,266 1,192 1,105 1,056

Operating figures as reported in each quarter’s results release or filing

Figure Quarter Latest A year before Change
HVP Components accounted for total company net sales Q3 FY2026 53.0% — —
HVP Delivery Devices accounted for total company net sales Q3 FY2026 11.0% — —
Standard Products accounted for total company net sales Q3 FY2026 19.0% — —

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.